Roche and Regeneron Team Up on Covid-19 Antibody Treatment

This post was originally published on this site

Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • Pharmaceutical companies Roche and Regeneron (ticker: REGN) are partnering on a possible Covid-19 antibody treatment, the companies said Wednesday.

Click here to read full article